Structure

1-Piperidinecarboxylicacid,4-[[(methylsulfonyl)oxy]methyl]-,1,1-dimethylethyl ester

CAS
161975-39-9
Catalog Number
ACM161975399
Category
Other Products
Molecular Weight
293.38
Molecular Formula
C12H23NO5S

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
161975-39-9, 1-BOC-4-METHANESULFONYLOXYMETHYL-PIPERIDINE, AG-E-11726, Tert-butyl 4-(methylsulfonyloxymethyl)piperidine-1-carboxylate, 1-N-BOC-4-METHANESULFONYLOXYMETHYLPIPERIDINE, tert-Butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate, tert-butyl 4-{[(methylsulfonyl)oxy]methyl}piperidine-1-carboxylate, AC1MCBWB, AC1Q1N1I, CTK4D1035, MolPort-002-344-727, ACT09066, ANW-55613, ZINC02576507, AKOS005069232, MCULE-5280441200, RP07616, RP22868, 1-BOC-4-MESYLOXYMETHYLPIPERIDINE, AK-61170
IUPAC Name
tert-butyl 4-(methylsulfonyloxymethyl)piperidine-1-carboxylate
SMILES
CC(C)(C)OC(=O)N1CCC(CC1)COS(=O)(=O)C
InChI Key
RXNQBVRCZIYUJK-UHFFFAOYSA-N
Boiling Point
418.8ºC at 760mmHg
Melting Point
73-76ºC
Flash Point
207.1ºC
Density
1.175g/cm³
Exact Mass
293.13000
H-Bond Acceptor
5
H-Bond Donor
0

Downstream Synthesis Route 1

  • 773837-37-9
  • 161975-39-9
  • 256411-39-9

Reference: [1] Patent: US2013/102621, 2013, A1, . Location in patent: Paragraph 0281; 0282

Downstream Synthesis Route 2

  • 161975-39-9
  • 145508-94-7

Reference: [1] Patent: US2002/13348, 2002, A1,

Downstream Synthesis Route 3

  • 161975-39-9
  • 158407-04-6

Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 96 - 112

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.